COMP <GO>
BAX vs UNH // REVENUE GROWTH (YOY)
Baxter International Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: BAX 3
— UNH 10
▲ REVENUE GROWTH (YOY) LEADER: BAX
LAST: $24.22 (+5.30%) • MKT CAP: $12.53B
revenue-growth
5.70%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
revenue-growth
3.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BAX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BAX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.10% | 88.31% | -58.21 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.40% | 12.38% | -14.78 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.79% | 6.25% | -3.46 | UNH | /fcf-yield <GO> |
| Operating Margin | -2.70% | 5.32% | -8.02 | UNH | /operating-margins <GO> |
| Net Profit Margin | -8.50% | 3.53% | -12.03 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 5.70% | 3.33% | +2.37 | BAX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.86% | 2.29% | +0.57 | BAX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 3.09 | -0.87 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.5 | 55.1 | -5.60 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.33 | +0.62 | BAX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 17.7x | +0.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.53B | $359.43B | -$346.90B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BAX REV | UNH REV | BAX GROSS % | UNH GROSS % | BAX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.24B | $447.57B | 30.1% | 88.7% | $339.0M | $16.07B |
| FY 2024 | $10.64B | $400.28B | 37.5% | 88.3% | $540.4M | $20.70B |
| FY 2023 | $10.36B | $371.62B | — | 89.6% | $1.26B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BAX // BETA 0.95
UNH // BETA 0.33